Founded in 2006, it is located in Taizhou City, Zhejiang Province, the most dynamic chemical API manufacture base in southeastern China.
Engaged in the production and sales of APIs like X-CT non-ionic iodine contrast agents, Hichi has obtained a number of invention patents. We has passed the CFDA’s GMP certification for APIs, as well as certifications such as ISO9001 quality management system, ISO14001 environmental system, and OHSAS18001 Occupational Health and Safety Assessment Series.
Strong Capability
Rich Experienced
Excellent team
Advanced technology
Diverse Products
Perfect after-sale service
Hichi Pharma is committed to the development of APIs of X-CT non-ionic iodine contrast agents, MRI contrast agents, cardiovascular, hypoglycemic etc.
Hichi Pharma is a national high-tech enterprise with a young and professional R&D team, advanced production and test equipment as well as perfect infrastructure; the new developed products and technologies have won national, provincial and municipal awards successively; the products have obtained the registration approval of the State Food and Drug Administration, passed the GMP inspection, and we are also promoting the certification of FDA and COS meanwhile.
The vice Secretary of Yuhuan Municipal Committee, Mayor of Yuhuan city, Mr. Niansheng Du, as well as the vice Mayor of Yuhuan city, Mr. Fuzhang Zhan and other municipal government leaders come to Hichi Pharma for pre-IPO investigations.
2022-05-27
Environmental impact evaluation publicity of technical improvement projects on Zhejiang Hichi Pharmaceutical Corporation Limited“Annual output of 440 tons Iohexol intermediates & 100 tons Iodixanol API”
2022-05-18